Updates are available Erratum dated 2017-08-24

Article History

First Online: 21 January 2017

Change Date: 24 August 2017

Change Type: Erratum

Change Details: An erratum to this article has been published.

Compliance with Ethical Standards

: The manuscript is not under consideration elsewhere. None of the manuscript contents have been previously published in any form. The figure is original. All authors have contributed to the manuscript and approved the submitted version.

: Jacob Thyssen and Yuki Andersen are supported by an unrestricted grant from the Lundbeck Foundation. Jacob Thyssen has participated in international and national advisory board meetings for Sanofi-Genzyme and Roche. Alexander Egeberg has received research funding from Pfizer and Eli Lilly, and honoraria as consultant and/or speaker from Pfizer, Eli Lilly, Novartis, Galderma, and Janssen Pharmaceuticals. Lone Skov has performed clinical trial for Regeneron, participated in advisory board meetings for Sanofi, and is supported by a grant from the Capital Region of Denmark, Foundation for Health Research.This work was performed independently through the authors’ academic university and hospital affiliations.

: This article does not contain any studies with human or animal subjects performed by any of the authors.